159 related articles for article (PubMed ID: 34624229)
1. Caught in the antiviral crossfire: Ganciclovir-associated mutagenesis in HSC transplant recipients.
Spencer Chapman M; Nangalia J
Cell Stem Cell; 2021 Oct; 28(10):1683-1685. PubMed ID: 34624229
[TBL] [Abstract][Full Text] [Related]
2. Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.
Santos Bravo M; Plault N; Sánchez Palomino S; Mosquera Gutierrez MM; Fernández Avilés F; Suarez Lledo M; Sabé Fernández N; Rovira M; Alain S; Marcos Maeso MÁ
J Infect Dis; 2021 Sep; 224(6):1024-1028. PubMed ID: 33475730
[TBL] [Abstract][Full Text] [Related]
3. Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients.
Gilbert C; Roy J; Belanger R; Delage R; Beliveau C; Demers C; Boivin G
Antimicrob Agents Chemother; 2001 Dec; 45(12):3669-71. PubMed ID: 11709367
[TBL] [Abstract][Full Text] [Related]
4. [Mutations in the
Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
[TBL] [Abstract][Full Text] [Related]
5. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
6. [Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].
Vejražková E; Hubáček P; Kutová R; Plíšková L; Košťál M; Štěpánová V; Zavřelová A; Radocha J; Malá E; Žák P
Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):160-8. PubMed ID: 26448304
[TBL] [Abstract][Full Text] [Related]
7. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
Noble S; Faulds D
Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
[TBL] [Abstract][Full Text] [Related]
8. Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.
Solano C; Giménez E; Piñana JL; Vinuesa V; Poujois S; Zaragoza S; Calabuig M; Navarro D
Bone Marrow Transplant; 2016 May; 51(5):718-21. PubMed ID: 26642339
[No Abstract] [Full Text] [Related]
9. Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.
Boivin G; Goyette N; Gilbert C; Humar A; Covington E
Transpl Infect Dis; 2005; 7(3-4):166-70. PubMed ID: 16390409
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
Avery RK; Arav-Boger R; Marr KA; Kraus E; Shoham S; Lees L; Trollinger B; Shah P; Ambinder R; Neofytos D; Ostrander D; Forman M; Valsamakis A
Transplantation; 2016 Oct; 100(10):e74-80. PubMed ID: 27495775
[TBL] [Abstract][Full Text] [Related]
11. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients.
de Kanter JK; Peci F; Bertrums E; Rosendahl Huber A; van Leeuwen A; van Roosmalen MJ; Manders F; Verheul M; Oka R; Brandsma AM; Bierings M; Belderbos M; van Boxtel R
Cell Stem Cell; 2021 Oct; 28(10):1726-1739.e6. PubMed ID: 34496298
[TBL] [Abstract][Full Text] [Related]
12. Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?
Singh N; Yu VL
Dig Dis Sci; 1998 Jun; 43(6):1190-2. PubMed ID: 9635606
[No Abstract] [Full Text] [Related]
13. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.
El Chaer F; Mori N; Shah D; Oliver N; Wang E; Jan A; Doan V; Tverdek F; Tayar J; Ariza-Heredia E; Chemaly RF
Antiviral Res; 2016 Nov; 135():91-96. PubMed ID: 27594527
[TBL] [Abstract][Full Text] [Related]
14. Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
Chong PP; Teiber D; Prokesch BC; Arasaratnam RJ; Peltz M; Drazner MH; Garg S
Transpl Infect Dis; 2018 Oct; 20(5):e12965. PubMed ID: 29989279
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient.
Göhring K; Feuchtinger T; Mikeler E; Lang P; Jahn G; Handgretinger R; Hamprecht K
J Mol Diagn; 2009 Jul; 11(4):364-8. PubMed ID: 19477945
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.
Fisher CE; Knudsen JL; Lease ED; Jerome KR; Rakita RM; Boeckh M; Limaye AP
Clin Infect Dis; 2017 Jul; 65(1):57-63. PubMed ID: 28369203
[TBL] [Abstract][Full Text] [Related]
17. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
Mylonakis E; Kallas WM; Fishman JA
Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
[TBL] [Abstract][Full Text] [Related]
18. Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
Kiehl MG; Basara N
Blood; 2001 Sep; 98(5):1626; author reply 1628. PubMed ID: 11547768
[No Abstract] [Full Text] [Related]
19. Study of cytomegalovirus resistance in allogeneic hematopoietic cell transplant recipients.
Guiu A; López-Aladid R; Cardeñoso L; Mosquera MM; de la Cámara R; Marcos MA
Med Clin (Barc); 2020 Jun; 154(11):433-439. PubMed ID: 31785805
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment with Letermovir in a Heart Transplant Recipient with UL97 Mutation Ganciclovir-Resistant Cytomegalovirus Colitis and Viremia.
Yanase T; Hatano M; Bujo C; Tsuji M; Ishida J; Amiya E; Okamoto K; Ando M; Shimada S; Kinoshita O; Fukushi S; Yamada S; Ono M; Komuro I
Int Heart J; 2023 Mar; 64(1):95-99. PubMed ID: 36682771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
